Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Plos One
|
October 8, 2013
Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo
Wen-Juan Wang, Yu Yao, Li-Li Jiang, et al.
Scientific Reports
|
July 2, 2017
ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy
Tao Wu, Xiao-An Ma, Guo-Qing Wang, et al.
Cancer Letters
|
August 25, 2014
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway
Ting-Hua Hu, Yu Yao, Shuo Yu, et al.
Oncotarget
|
February 4, 2016
Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study
Min-Cong Wang, Min Jiao, Tao Wu, et al.
Oncology Reports
|
November 6, 2014
In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines
Min-Cong Wang, Xuan Liang, Zhi-Yan Liu, et al.
Oncology Reports
|
April 5, 2014
Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma
Li-Li Han, Hao-Cheng Nan, Tao Tian, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 1, 2006
[Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer]
Jun-ling Li, Xiang-ru Zhang, Ji-wei Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 1, 2006
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors]
Pin Zhang, Feng-yi Feng, Ling-ying Wu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 13, 2006
[Docetaxel in the treatment of advanced breast cancer ]
Zi-Ping Wang, Yan Sun, Xiang-Ru Zhang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
November 26, 2008
[A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy]
Zi-ping Wang, Yan Sun, Xiang-ru Zhang, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Plos One
|
October 8, 2013
Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo
Wen-Juan Wang, Yu Yao, Li-Li Jiang, et al.
Scientific Reports
|
July 2, 2017
ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy
Tao Wu, Xiao-An Ma, Guo-Qing Wang, et al.
Cancer Letters
|
August 25, 2014
SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway
Ting-Hua Hu, Yu Yao, Shuo Yu, et al.
Oncotarget
|
February 4, 2016
Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study
Min-Cong Wang, Min Jiao, Tao Wu, et al.
Oncology Reports
|
November 6, 2014
In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines
Min-Cong Wang, Xuan Liang, Zhi-Yan Liu, et al.
Oncology Reports
|
April 5, 2014
Expression and significance of the novel tumor-suppressor gene SMG-1 in hepatocellular carcinoma
Li-Li Han, Hao-Cheng Nan, Tao Tian, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 1, 2006
[Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer]
Jun-ling Li, Xiang-ru Zhang, Ji-wei Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
August 1, 2006
[Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors]
Pin Zhang, Feng-yi Feng, Ling-ying Wu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 13, 2006
[Docetaxel in the treatment of advanced breast cancer ]
Zi-Ping Wang, Yan Sun, Xiang-Ru Zhang, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
November 26, 2008
[A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy]
Zi-ping Wang, Yan Sun, Xiang-ru Zhang, et al.
Page
of 9